Los Angeles Capital Management & Equity Research Inc increased Nucor Corp (NUE) stake by 1592.3% reported in 2017Q4 SEC filing. Los Angeles Capital Management & Equity Research Inc acquired 63,676 shares as Nucor Corp (NUE)’s stock declined 6.71%. The Los Angeles Capital Management & Equity Research Inc holds 67,675 shares with $4.30M value, up from 3,999 last quarter. Nucor Corp now has $20.81B valuation. The stock increased 2.00% or $1.28 during the last trading session, reaching $65.41. About 3.65 million shares traded or 29.26% up from the average. Nucor Corporation (NYSE:NUE) has risen 1.23% since April 18, 2017 and is uptrending. It has underperformed by 10.32% the S&P500.
The stock of CryoLife, Inc. (NYSE:CRY) hit a new 52-week high and has $24.51 target or 3.00% above today’s $23.80 share price. The 9 months bullish chart indicates low risk for the $871.82M company. The 1-year high was reported on Apr, 18 by Barchart.com. If the $24.51 price target is reached, the company will be worth $26.15M more. The stock increased 1.93% or $0.45 during the last trading session, reaching $23.8. About 113,593 shares traded or 4.44% up from the average. CryoLife, Inc. (NYSE:CRY) has risen 19.34% since April 18, 2017 and is uptrending. It has outperformed by 7.79% the S&P500.
Since October 23, 2017, it had 0 buys, and 7 selling transactions for $8.43 million activity. $2.67 million worth of Nucor Corporation (NYSE:NUE) shares were sold by Frias James D. On Wednesday, March 7 the insider HAYNES VICTORIA F sold $207,347. NAPOLITAN RAYMOND S JR had sold 8,000 shares worth $520,880 on Monday, March 19. $2.66M worth of Nucor Corporation (NYSE:NUE) was sold by HALL LADD R. 15,131 Nucor Corporation (NYSE:NUE) shares with value of $913,959 were sold by FERRIOLA JOHN J. 9,003 shares valued at $537,659 were sold by Utermark D. Chad on Friday, October 27.
Los Angeles Capital Management & Equity Research Inc decreased Procter & Gamble Co (NYSE:PG) stake by 287,830 shares to 1.52M valued at $139.59M in 2017Q4. It also reduced Garmin Ltd (NASDAQ:GRMN) stake by 32,753 shares and now owns 152,622 shares. Fleetcor Technologies I (NYSE:FLT) was reduced too.
Investors sentiment increased to 0.93 in 2017 Q4. Its up 0.04, from 0.89 in 2017Q3. It increased, as 53 investors sold NUE shares while 231 reduced holdings. 92 funds opened positions while 173 raised stakes. 244.43 million shares or 5.15% more from 232.46 million shares in 2017Q3 were reported. Old Mutual Customised Solutions (Proprietary) reported 0.13% in Nucor Corporation (NYSE:NUE). The Connecticut-based Bridgewater Assocs LP has invested 0.02% in Nucor Corporation (NYSE:NUE). Fukoku Mutual Life Ins reported 2,500 shares. Bancorporation Of The Ozarks holds 23,069 shares. Dimensional Fund Advsrs Ltd Partnership has 4.72M shares. Toronto Dominion Natl Bank reported 138,033 shares stake. State Board Of Administration Of Florida Retirement stated it has 0.08% in Nucor Corporation (NYSE:NUE). Plante Moran Fincl Advisors Limited Liability Corporation holds 0.01% of its portfolio in Nucor Corporation (NYSE:NUE) for 310 shares. Moreover, First Financial In has 0.31% invested in Nucor Corporation (NYSE:NUE). Chevy Chase Holdg Incorporated owns 360,476 shares. State Street has 0.09% invested in Nucor Corporation (NYSE:NUE). Wright Invsts Serv Incorporated owns 4,870 shares for 0.1% of their portfolio. Blue Edge Capital Limited Co reported 5,600 shares or 0.14% of all its holdings. Enterprise Financial Services invested in 245 shares. Lombard Odier Asset Mgmt (Usa) Corp reported 9,361 shares.
Among 20 analysts covering Nucor Corporation (NYSE:NUE), 13 have Buy rating, 0 Sell and 7 Hold. Therefore 65% are positive. Nucor Corporation had 82 analyst reports since July 22, 2015 according to SRatingsIntel. The company was initiated on Monday, August 22 by Citigroup. Morgan Stanley upgraded the stock to “Overweight” rating in Monday, February 13 report. Jefferies maintained the shares of NUE in report on Tuesday, January 9 with “Buy” rating. The stock of Nucor Corporation (NYSE:NUE) has “Buy” rating given on Monday, August 21 by Jefferies. On Tuesday, December 6 the stock rating was upgraded by Berenberg to “Buy”. Barclays Capital maintained the shares of NUE in report on Wednesday, July 13 with “Overweight” rating. The stock of Nucor Corporation (NYSE:NUE) earned “Buy” rating by Argus Research on Monday, December 12. Jefferies maintained the stock with “Buy” rating in Wednesday, January 31 report. On Monday, January 8 the stock rating was maintained by Bank of America with “Buy”. On Wednesday, January 31 the stock rating was maintained by Credit Suisse with “Buy”.
Since December 15, 2017, it had 0 insider purchases, and 3 sales for $169,448 activity. 5,000 shares valued at $105,448 were sold by McCall Ronald D on Thursday, March 8. Another trade for 1,000 shares valued at $20,000 was made by RONALD C ELKINS on Friday, December 15.
Analysts await CryoLife, Inc. (NYSE:CRY) to report earnings on April, 25. They expect $-0.04 EPS, down 144.44% or $0.13 from last year’s $0.09 per share. After $0.11 actual EPS reported by CryoLife, Inc. for the previous quarter, Wall Street now forecasts -136.36% negative EPS growth.
CryoLife, Inc., together with its subsidiaries, makes and distributes medical devices worldwide. The company has market cap of $871.82 million. It also processes and distributes implantable human tissues for use in cardiac and vascular surgeries. It has a 222.43 P/E ratio. The firm operates in two divisions, Medical Devices and Preservation Services.
Among 4 analysts covering Cryolife (NYSE:CRY), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Cryolife has $28.0 highest and $14 lowest target. $22.17’s average target is -6.85% below currents $23.8 stock price. Cryolife had 12 analyst reports since April 13, 2016 according to SRatingsIntel. The rating was upgraded by Ladenburg Thalmann to “Buy” on Friday, February 17. Northland Capital maintained it with “Buy” rating and $23.5 target in Monday, November 13 report. Northland Capital maintained CryoLife, Inc. (NYSE:CRY) on Tuesday, July 25 with “Buy” rating. The rating was maintained by Canaccord Genuity with “Buy” on Tuesday, October 31. The stock has “Buy” rating by Canaccord Genuity on Tuesday, July 25. Northland Capital initiated it with “Outperform” rating and $23.50 target in Monday, January 9 report. Northland Capital maintained it with “Buy” rating and $23.50 target in Monday, May 1 report. The rating was maintained by Canaccord Genuity with “Buy” on Thursday, March 8. The firm has “Buy” rating given on Wednesday, June 15 by Lake Street. Canaccord Genuity initiated the shares of CRY in report on Wednesday, April 13 with “Buy” rating.
Investors sentiment decreased to 1.33 in 2017 Q4. Its down 0.26, from 1.59 in 2017Q3. It is negative, as 14 investors sold CryoLife, Inc. shares while 29 reduced holdings. 13 funds opened positions while 44 raised stakes. 24.23 million shares or 2.29% more from 23.69 million shares in 2017Q3 were reported. Dimensional Fund Limited Partnership holds 2.01M shares or 0.02% of its portfolio. 76,868 are held by Jpmorgan Chase. Moreover, Barclays Public Limited Co has 0% invested in CryoLife, Inc. (NYSE:CRY). Principal Inc reported 258,722 shares. State Of Alaska Department Of Revenue accumulated 0% or 6,607 shares. Legal General Gp Public Ltd Co accumulated 60,639 shares. Next Century Growth Invsts Ltd Limited Liability Company has invested 0.18% in CryoLife, Inc. (NYSE:CRY). Bank & Trust Of New York Mellon, New York-based fund reported 399,517 shares. Royal Bancorp Of Canada stated it has 0% of its portfolio in CryoLife, Inc. (NYSE:CRY). State Street Corp has invested 0% in CryoLife, Inc. (NYSE:CRY). Gsa Capital Ptnrs Llp holds 0.01% or 12,142 shares in its portfolio. Alliancebernstein L P holds 0% or 38,468 shares. Capital Global Investors has invested 0.02% in CryoLife, Inc. (NYSE:CRY). Mason Street Advsr Limited Liability Corporation reported 8,699 shares. 1,519 are held by State Bank Of Montreal Can.